Deutsche Bank Ag\ Oragenics Inc Transaction History

Deutsche Bank Ag\

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$0.43 - $0.75 $15,315 - $26,712	-35,617 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.42 - $0.62 $14,959 - $22,082	35,617 New	35,617 $18,000
Q3 2019 Nov 14, 2019	SELL	$0.36 - $0.64 $7,068 - $12,567	-19,636 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$0.46 - $0.6 $9,032 - $11,781	19,636 New	19,636 $9,000
Q3 2018 Nov 14, 2018	SELL	$0.38 - $1.42 $684 - $2,556	-1,800 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$1.16 - $2.0 $2,088 - $3,600	1,800 New	1,800 $2,000

Ticker OGEN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 116,395,000
Market Cap $40.7M
Description
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.